drugset / Trial / NCT00277576
Safety Study of HBV DNA Vaccine to Treat Patients With Chronic Hepatitis B Infection
RandomizedSingle-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate how well the vaccine is tolerated at sites where administrations are given and any effects it may have on subjects' wellbeing. The study will also test the ability of vaccine to reduce hepatitis B disease.
Timeline
- Start
- 2006-01
- Primary completion
- —
- Completion
- 2007-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | pPDPSC18 | Vaccine | — | Other |